HOME >> MEDICINE >> NEWS
Diet high in vitamin C decreases stroke risk, especially among smokers

ST. PAUL, MN Eating a diet high in vitamin C may decrease your risk of stroke, particularly if you smoke, according to a study published in the November 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

The study found that people with the lowest amount of vitamin C in their diets were 30 percent more likely to have a stroke than people with the highest amount of vitamin C in their diets. Smokers with diets high in vitamin C were more than 70 percent less likely to have a stroke than smokers with diets low in vitamin C.

Antioxidants such as vitamin C may protect cells from oxidative stress, which plays a role in stroke.

Vitamin E was also protective for smokers. Those with diets high in vitamin E were more than 20 percent less likely to have a stroke than those with diets low in vitamin E. No similar advantage was found in non-smokers whose diets were high in vitamin E.

"Of course these study findings do not justify smoking. No one should smoke," said study author Monique Breteler, MD, PhD, of Erasmus Medical Center in Rotterdam. "But it is good news that high levels of antioxidants may help reduce the risk of stroke in smokers."

The study involved 5,197 people age 55 or older in Rotterdam, the Netherlands. All of the participants had no cognitive problems, were living independently and had never had a stroke.

The participants were then tracked for an average of 6.4 years. During that time, 253 people had strokes.

People with the highest amount of vitamin C in their diets consumed greater than 133 mg of vitamin C per day. People with the lowest amount in their diets consumed less than 95 mg per day.

To determine their levels of vitamin C and other antioxidants, participants first indicated on a checklist all foods and drinks they had consumed at least twice a month during the past year. Then they were interviewed by a dietician about their diet.

The use of diet
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
10-Nov-2003


Page: 1 2

Related medicine news :

1. Not enough evidence that multivitamins prevent infections in the elderly
2. Folic acid and vitamin B12 decrease risk of hip fracture in stroke patients
3. Calcium and vitamin D most effective for treatment of Crohns-related bone loss
4. High doses of vitamin E supplements do more harm than good
5. Study shows high-dose vitamin E supplements may increase risk of dying
6. Center refutes finding that added sugars displace vitamins and minerals
7. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
8. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
9. International experts discuss latest research on vitamin E & health
10. Red palm oil as a means of combating vitamin A deficiency
11. Low vitamin B12 is associated with poorer memory in older people with high risk for Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diet high vitamin decreases stroke risk especially among smokers

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: